Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients

For cardiac transplant (CTx) recipients, the recommended everolimus (EVL) dose is 0.75 mg bid or 1.5 mg bid and the target trough blood level is 3–8 μg/L. We studied a cohort of 56 CTx patients with chronic kidney disease receiving 0.75 mg bid EVL to maintain blood levels of 5–8 ug/L (designated RD...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fuchs, Uwe, Zittermann, Armin, Schulz, Uwe, Gummert, Jan F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2012
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3345239/
https://ncbi.nlm.nih.gov/pubmed/22577516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/976921
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky